What groups of people are more prone to complications after Bariatric Surgery, and does acid suppression in the stomach play a role? A mulitregister study
| ISRCTN | ISRCTN12963684 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN12963684 |
| Secondary identifying numbers | PPI-GBP 001 |
- Submission date
- 20/09/2016
- Registration date
- 04/11/2016
- Last edited
- 21/04/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nutritional, Metabolic, Endocrine
Plain English summary of protocol
Background and study aims
Since obesity (being very overweight) is a growing health problem all over the world, more and more people are having weight-loss surgery because of its proven effects on obesity and related health problems. Having an operation is never risk free, and although weight-loss surgery is relatively safe, there are certain groups of people who are more at risk for complications. Drugs reducing stomach acid are used with varying degrees of success for the purpose of reducing complications, but it’s not clear how great this effect is and who benefits from it. The purpose of this study is to identify groups of patients that are at higher risk for complications and who could benefit most from acid suppression in the stomach.
Who can participate?
Patients that had weight loss surgery (gastric bypass) in Sweden between 2009-2014 and registered in the Scandinavian Obesity Surgery Registry.
What does the study involve?
Data is taken from the Scandinavian Obesity Surgery Register (SOReg) for patients that have had first time gastric bypass surgeries from 2009 through 2014. In addition, matching socio-economic data (that is data describing a person’s age, gender and income for example) is taken from Statistics Sweden and records on proton-pump inhibition prescriptions from the National Board of Health and Welfare's Drug Registry. Analysis is then done on this data, to see whether what type of patient is least likely to develop complications after weight loss surgery.
What are the possible benefits and risks of participating?
Not provided at time of registration
Where is the study run from?
Department of Surgery and Orthopedics, Lycksele Hospital
When is the study starting and how long is it expected to run for?
October 2016 to May 2017
Who is funding the study?
1. County Council of Västerbotten (Sweden)
2. Umeå University (Sweden)
Who is the main contact?
1. Dr Jeff Wennerlund (public)
Jeff.Wenerlund@umu.se
2. Professor Ulf Gunnarsson (scientific)
Ulf.Gunnarsson@umu.se
Contact information
Public
Lycksele Hospital
Department of Surgery and Orthopedics
Lycksele
92182
Sweden
 ORCID ID |
0000-0003-0603-751X |
|---|---|
| Phone | +46 70-438 1109 |
| Jeff.Wennerlund@umu.se |
Scientific
Department of Surgical and Perioperative Sciences
Umeå Univerisity
Umeå
901 87
Sweden
| Phone | +46 90-7852909 |
|---|---|
| Ulf.Gunnarsson@umu.se |
Study information
| Study design | Single-site observational cohort study |
|---|---|
| Primary study design | Observational |
| Secondary study design | Cohort study |
| Study setting(s) | Hospital |
| Study type | Prevention |
| Scientific title | Which sub-groups of people are more prone to complications after complications after Bariatric Surgery, and does post-operative prophylaxis with proton-pump inhibition play a role? A multiregister study |
| Study acronym | PPI-GBP |
| Study objectives | Which combinations of factors predispose to complications after gastric bypass surgery? Does prophylaxis with proton-pump inhibition play a role? What differernces can be acertained from gender, age, existing co-morbidity, BMI, and socio-economic factors? The underlying hypothesis is that certain factors play a role in complications, and if/where proton-pump inhibition has a place in the clinical setting. |
| Ethics approval(s) | Regional Ethics Committee of Umeå 12/1/2016. Case number 2015/367-31 |
| Health condition(s) or problem(s) studied | Morbid obesity |
| Intervention | Patient specific gender, age, BMI, existing co-morbidities, socio-economic status, and the presence of proton-pump inhibition is to be collected and compared with the occurrence of post-operative complications in a longitudinal multi-variate study . After collecting data from the three registers, statistical analyses will be made focusing on the outcome of post-operative complications and their severity (according to the Clavien-Dindo scale) and necessary interventions, if any. Logistic regression models will be used in multi-variate analyses to pinpoint those factors (patient specific age, gender, BMI, pre-existing health problems, occurrence of proton-pump inhibition prophylaxis, and socioeconomic factors) that are associated with higher rates of complications, both as a total rate and for each individual complication. The rate of complications are also controlled against the Drug Registry if the prophylaxis was actually retrieved, or if therapy was prescribed and retrieved for other reasons. |
| Intervention type | Drug |
| Pharmaceutical study type(s) | |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | Omeprazole, esomprazole |
| Primary outcome measure | Identification of sub-groups according to age, gender, body mass index measured in body weight (kg)/ body length (m) squared, and pre-existing health problems at baseline that have less post-operative complications and severity thereof (according to the Clavien-Dindo scale) due to prophylaxis with proton-pump inhibition, measured at 30 days and at 1 and 2 years post-operatively. |
| Secondary outcome measures | Identification of socioeconomic factors at baseline that impact related health problems, the rate of post-operative complications, and occurrence and adherence to proton-pump prophylaxis. |
| Overall study start date | 31/10/2016 |
| Completion date | 31/05/2017 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | All |
| Sex | Both |
| Target number of participants | ca 39,000 |
| Total final enrolment | 37301 |
| Key inclusion criteria | Patients eligible and accepted for primary laparoscopic gastric bypass surgery in Sweden during 2009-2014, and registered in the Scandinavian Obesity Surgery Registry (SOReg). |
| Key exclusion criteria | Participants that do not fulfill inclusion criteria |
| Date of first enrolment | 31/10/2016 |
| Date of final enrolment | 31/01/2017 |
Locations
Countries of recruitment
- Sweden
Study participating centre
Lycksele lasarett
Lycksele
92182
Sweden
Sponsor information
Government
Köksvägen 11
Umeå
901 89
Sweden
| Phone | +46 90-785 0000 |
|---|---|
| landstinget@vll.se | |
| Website | www.vll.se |
"ROR" |
https://ror.org/04xvhsp09 |
Funders
Funder type
University/education
No information available
Government organisation / Universities (academic only)
- Alternative name(s)
- Umeå University, Ubmeje universitiähta, Universitas Umensis
- Location
- Sweden
Results and Publications
| Intention to publish date | 18/01/2020 |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not expected to be made available |
| Publication and dissemination plan | The results are to be published in a peer-review scientific journal. The results will be presented within the local research network, and at national and international scientific conferences. |
| IPD sharing plan | Collecting data from these registers is done under certain conditions. These include that the data may not be shared with a third party, is to be used only according to the purpose stated in the applications and the signed contracts, and that the data is to be erased after the project is completed. Further the information is to be handled in the same manner as patient charts, with utmost confidentiality, with identifying information separate from the raw data and calculation files. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/05/2020 | 21/04/2020 | Yes | No |
Editorial Notes
21/04/2020: The following changes were made to the trial record:
1. Publication reference added.
2. The total final enrolment was added.
19/11/2019: The intention to publish date was changed from 12/05/2019 to 18/01/2020.
01/11/2019: Internal review.
12/03/2019: The intention to publish date was changed from 28/02/2018 to 12/05/2019.
23/10/2017: The intention to publish date was changed from 30/04/2017 to 28/02/2018.
